Stem Cell Assay Market Forecast to 2021 (1)

1
MarketsandMarkets Presents
Stem Cell Assay Market worth 1,363.3 Million USD
by 2021
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
2
The report "Stem Cell Assay Market by Type
(Viability, Differentiation, Cell
Identification), Kit (Mesenchymal, IPSCS,
Hematopoietic), Product (Flow Cytometer,
Detection Kit), Application (Regenerative
Medicines, Drug Development), End User - Forecast
to 2021"The global stem cell assay market is
expected to reach USD 1,363.3 Million by 2021
from USD 536.6 Million in 2016, at a CAGR of
20.5 from 2016 to 2021. Browse 73 market data
Tables and 93 Figures spread through 182 Pages
and in-depth TOC on "Stem Cell Assay Market
http//www.marketsandmarkets.com/Market-Reports
/stem-cell-assay-market-47610330.html Early
buyers will receive 10 customization on This
report. Market growth can be attributed to the
high prevalence of chronic diseases, increasing
investment in research related activities, and
technological advancements. However, stringent
regulatory policies and high cost of stem cell
based therapies are major factors restraining the
growth of this market.
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
3
In this report, the global stem cell assay market
has been segmented based on type of assay, by
kits, by detection, by instruments, by
application, end-user, and region. On the basis
of type, the market has been segmented into
viability/cytotoxicity, isolation purification,
cell identification, proliferation,
differentiation, function and apoptosis. The
viability/cytotoxicity segment is expected to
account for the largest share of the market in
2016. The high growth in this segment is
primarily attributed to the increasing focus of
the pharmaceutical industries on drug screening
which resulted in the increasing the demand for
stem cell assays. Based on kits, the stem cell
assay market has been segmented into adult stem
cell kits and human embryonic stem cell kits. The
adult stem cell kits are further segmented into
mesenchymal stem cell kits, induced pluripotent
stem cell kits (IPSCs), hematopoietic stem cell
kits, umbilical cord stem cell kits and neuronal
stem cell kits.
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
4
The adult stem cell kits segment is projected to
witness the highest CAGR from 2016 to 2021. The
high growth in this segment can be primarily
attributed to the effectiveness of this type of
kits in cell analysis. The Sample Report For
This Report_at_ http//www.marketsandmarkets.com/req
uestsample.asp?id47610330 Based on application,
the global stem cell assay market is segmented
into regenerative medicine therapy development,
drug discovery and development and clinical
research. The regenerative medicine therapy
development segment is further segmented into
orthopedic musculoskeletal, spine,
cardiovascular, oncology, central nervous system,
dermatology, diabetes and others. The
regenerative medicine therapy development
segment is projected to witness the highest
growth rate during the forecast period due to the
increase in incidences of chronic diseases which
further leads to the increased demand for
regenerative medicines.
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
5
Geographically, the stem cell assay market is
dominated by North America, followed by Europe,
the Asia-Pacific region, and the Rest of the
World (RoW). Growth in the North American region
is primarily driven by the increasing incidence
and prevalence of chronic diseases and increasing
patient pool in North American countries. Get
The PDF Brochure For This Report_at_ http//www.marke
tsandmarkets.com/pdfdownload.asp?id47610330 The
major players in the global stem cell assay
market are GE Healthcare (U.K.), Promega
Corporation (U.S.), Thermo Fisher Scientific Inc.
(U.S.), Merck KGaA (Germany), Cell Biolabs, Inc.
(U.S.), Hemogenix Inc. (U.S.), STEMCELL
Technologies Inc. (CA), Bio-Rad Laboratories, Inc
(U.S.), Bio-Techne Corporation (U.S.), and
Cellular Dynamics International, Inc. (U.S.).
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/st
em-cell-assay-market-47610330.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets